Availability of MudPIT data for classification of biological samples

Journal of Clinical Bioinformatics

Volumn 3, Issue 1, 2013, Pages

  Silvestre, Dario D ^a   Zoppis, Italo ^b   Brambilla, Francesca ^a   Bellettato, Valeria ^a   Mauri, Giancarlo ^b   Mauri, Pierluigi ^a  

^a INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Clinical proteomics; Label free quantification; MudPIT; Sample classification; SVM

Indexed keywords

EID: 84896325464     PISSN: None     EISSN: 20439113     Source Type: Journal    
DOI: 10.1186/2043-9113-3-1     Document Type: Article

References (45)

1. Palmblad M, Tiss A, Cramer R. Mass spectrometry in clinical proteomics - from the present to the future. Proteomics Clin Appl 2009, 3:6-17. [http://dx.doi.org/10.1002/prca.200800090], 10.1002/prca.200800090, 21136932.
2. Ressom HW, Varghese RS, Zhang Z, Xuan J, Clarke R. Classification algorithms for phenotype prediction in genomics and proteomics. Front Biosci 2008, 13:691-708. 10.2741/2712, 2204040, 17981580.
3. Frenzel J, Gessner C, Sandvoss T, Hammerschmidt S, Schellenberger W, Sack U, Eschrich K, Wirtz H. Outcome prediction in pneumonia induced ALI/ARDS by clinical features and peptide patterns of BALF determined by mass spectrometry. PLoS One 2011, 6(10):e25544. [http://dx.doi.org/10.1371/journal.pone.0025544], 10.1371/journal.pone.0025544, 3184998, 21991318.
4. Sampson DL, Parker TJ, Upton Z, Hurst CP. A comparison of methods for classifying clinical samples based on proteomics data: a case study for statistical and machine learning approaches. PLoS One 2011, 6(9):e24973. [http://dx.doi.org/10.1371/journal.pone.0024973], 10.1371/journal.pone.0024973, 3182169, 21969867.
5. Waloszczyk P, Janus T, Alchimowicz J, Grodzki T, Borowiak K. Proteomic patterns analysis with multivariate calculations as a promising tool for prompt differentiation of early stage lung tissue with cancer and unchanged tissue material. Diagn Pathol 2011, 6:22. [http://dx.doi.org/10.1186/1746-1596-6-22], 10.1186/1746-1596-6-22, 3068937, 21418626.
6. Rajalahti T, Kroksveen AC, Arneberg R, Berven FS, Vedeler CA, Myhr KM, Kvalheim OM. A multivariate approach to reveal biomarker signatures for disease classification: application to mass spectral profiles of cerebrospinal fluid from patients with multiple sclerosis. J Proteome Res 2010, 9(7):3608-3620. [http://dx.doi.org/10.1021/pr100142m], 10.1021/pr100142m, 20499859.
7. Camaggi CM, Zavatto E, Gramantieri L, Camaggi V, Strocchi E, Righini R, Merina L, Chieco P, Bolondi L. Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification. Clin Chem Lab Med 2010, 48(9):1319-1326. [http://dx.doi.org/10.1515/CCLM.2010.248].
8. Kim HK, Reyzer ML, Choi IJ, Kim CG, Kim HS, Oshima A, Chertov O, Colantonio S, Fisher RJ, Allen JL, Caprioli RM, Green JE. Gastric cancer-specific protein profile identified using endoscopic biopsy samples via MALDI mass spectrometry. J Proteome Res 2010, 9(8):4123-4130. [http://dx.doi.org/10.1021/pr100302b], 10.1021/pr100302b, 3441055, 20557134.
9. Balog CIA, Alexandrov T, Derks RJ, Hensbergen PJ, van Dam GJ, Tukahebwa EM, Kabatereine NB, Thiele H, Vennervald BJ, Mayboroda OA, Deelder AM. The feasibility of MS and advanced data processing for monitoring Schistosoma mansoni infection. Proteomics Clin Appl 2010, 4(5):499-510. [http://dx.doi.org/10.1002/prca.200900158].
10. Chinello C, Gianazza E, Zoppis I, Mainini V, Galbusera C, Picozzi S, Rocco F, Galasso G, Bosari S, Ferrero S, Perego R, Raimondo F, Bianchi C, Pitto M, Signorini S, Brambilla P, Mocarelli P, Galli K, Magni F. Serum biomarkers of renal cell carcinoma assessed using a protein profiling approach based on clinProt technique. Urology 2010, 75(4):842-847. 10.1016/j.urology.2009.09.050, 19963255.
11. Lin Q, Peng Q, Yao F, Pan XF, Xiong LW, Wang Y, Geng JF, Feng JX, Han BH, Bao GL, Yang Y, Wang X, Jin L, Guo W, Wang JC. A classification method based on principal components of SELDI spectra to diagnose of lung adenocarcinoma. PLoS One 2012, 7(3):e34457. [http://dx.doi.org/10.1371/journal.pone.0034457], 10.1371/journal.pone.0034457, 3312904, 22461913.
12. Fan Y, Wang J, Yang Y, Liu Q, Fan Y, Yu J, Zheng S, Li M, Wang J. Detection and identification of potential biomarkers of breast cancer. J Cancer Res Clin Oncol 2010, 136(8):1243-1254. [http://dx.doi.org/10.1007/s00432-010-0775-1], 10.1007/s00432-010-0775-1, 20237941.
13. Tang KL, Li TH, Xiong WW, Chen K. Ovarian cancer classification based on dimensionality reduction for SELDI-TOF data. BMC Bioinformatics 2010, 11:109. [http://dx.doi.org/10.1186/1471-2105-11-109], 10.1186/1471-2105-11-109, 2846906, 20187963.
14. Van Gorp T, Cadron I, Daemen A, De Moor B, Waelkens E, Vergote I. Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS. Proteome Sci 2012, 10:41. [http://dx.doi.org/10.1186/1477-5956-10-41], 10.1186/1477-5956-10-41, 3493309, 22694804.
15. Wiesner C, Hannum C, Reckamp K, Figlin R, Dubridge R, Roy SM, Lin S, Becker CH, Jones T, Hiller J, Cheville JC, Wilson K. Consistency of a two clinical site sample collection: a proteomics study. Proteomics Clin Appl 2010, 4(8-9):726-738. [http://dx.doi.org/10.1002/prca.200900206], 10.1002/prca.200900206, 21137090.
16. Gambin A, Szczurek E, Dutkowski J, Bakun M, Dadlez M. Classification of peptide mass fingerprint data by novel no-regret boosting method. Comput Biol Med 2009, 39(5):460-473. [http://dx.doi.org/10.1016/j.compbiomed.2009.03.006], 10.1016/j.compbiomed.2009.03.006, 19386298.
17. Perez-Riverol Y, Audain E, Millan A, Ramos Y, Sanchez A, Vizcaino JA, Wang R, Mller M, Machado YJ, Betancourt LH, González LJ, Padrn G, Besada V. Isoelectric point optimization using peptide descriptors and support vector machines. J Proteomics 2012, 75(7):2269-2274. [http://dx.doi.org/10.1016/j.jprot.2012.01.029], 10.1016/j.jprot.2012.01.029, 22326964.
18. Ding J, Shi J, Wu FX. SVM-RFE based feature selection for tandem mass spectrum quality assessment. Int J Data Min Bioinform 2011, 5:73-88. 10.1504/IJDMB.2011.038578, 21491845.
19. Webb-Robertson BJM. Support vector machines for improved peptide identification from tandem mass spectrometry database search. Methods Mol Biol 2009, 492:453-460. [http://dx.doi.org/10.1007/978-1-59745-493-3_28], 10.1007/978-1-59745-493-3_28, 19241051.
20. Baczek T, Kaliszan R. Predictions of peptides' retention times in reversed-phase liquid chromatography as a new supportive tool to improve protein identification in proteomics. Proteomics 2009, 9(4):835-847. [http://dx.doi.org/10.1002/pmic.200800544], 10.1002/pmic.200800544, 19160394.
21. Gaspari M, Verhoeckx KCM, Verheij ER, van der Greef J. Integration of two-dimensional LC-MS with multivariate statistics for comparative analysis of proteomic samples. Anal Chem 2006, 78(7):2286-2296. [http://dx.doi.org/10.1021/ac052000t], 10.1021/ac052000t, 16579610.
22. Sodek KL, Evangelou AI, Ignatchenko A, Agochiya M, Brown TJ, Ringuette MJ, Jurisica I, Kislinger T. Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT). Mol Biosyst 2008, 4(7):762-773. [http://dx.doi.org/10.1039/b717542f], 10.1039/b717542f, 18563251.
23. Simioniuc A, Campan M, Lionetti V, Marinelli M, Aquaro GD, Cavallini C, Valente S, Di Silvestre D, Cantoni S, Bernini F, Simi C, Pardini S, Mauri P, Neglia D, Ventura C, Pasquinelli G, Recchia FA. Placental stem cells pre-treated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study. Cardiovasc Res 2011, 90(3):546-556. [http://dx.doi.org/10.1093/cvr/cvr018], 10.1093/cvr/cvr018, 21257613.
24. Mauri P, Scigelova M. Multidimensional protein identification technology for clinical proteomic analysis. Clin Chem Lab Med 2009, 47(6):636-646. [http://dx.doi.org/10.1515/CCLM.2009.165].
25. Yates JR, Ruse CI, Nakorchevsky A. Proteomics by mass spectrometry: approaches, advances, and applications. Annu Rev Biomed Eng 2009, 11:49-79. [http://dx.doi.org/10.1146/annurev-bioeng-061008-124934], 10.1146/annurev-bioeng-061008-124934, 19400705.
26. Mauri P, Scarpa A, Nascimbeni AC, Benazzi L, Parmagnani E, Mafficini A, Della Peruta M, Bassi C, Miyazaki K, Sorio C. Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J 2005, 19(9):1125-1127. [http://dx.doi.org/10.1096/fj.04-3000fje].
27. Park SK, Venable JD, Xu T, Yates JR 3. A quantitative analysis software tool for mass spectrometry-based proteomics. Nat Methods 2008, 5(4):319-322. [http://dx.doi.org/10.1038/nmeth.1195], 3509211, 18345006.
28. Bergamini G, Di Silvestre D, Mauri P, Cigana C, Bragonzi A, De Palma A, Benazzi L, Døring G, Assael BM, Melotti P, Sorio C. MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects. Integr Biol (Camb) 2012, 4(3):270-279. [http://dx.doi.org/10.1039/c2ib00127f].
29. Guyon I, Gunn S, Nikravesh M, Zadeh LA(Feature Extraction: Foundations and Applications (Studies in Fuzziness and Soft Computing) 2006, Berlin Heidelberg: Springer-Verlag, (ISBN 978-3-540-35488-8).
30. Cristianini N, Schawe-Taylor J. An Introduction to Support Vector Machines and Other Kernel-Based Learning Methods 2000, New York, NY, USA: Cambridge University Press, (ISBN 9780521780193).
31. Mauri P, Dehi{dotless} G. A proteomic approach to the analysis of RNA degradosome composition in Escherichia coli. Methods Enzymol 2008, 447:99-117. [http://dx.doi.org/10.1016/S0076-6879(08)02206-4].
32. Brambilla F, Lavatelli F, Di Silvestre D, Valentini V, Rossi R, Palladini G, Obici L, Verga L, Mauri P, Merlini G. Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue. Blood 2012, 119(8):1844-1847. [http://dx.doi.org/10.1182/blood-2011-07-365510], 10.1182/blood-2011-07-365510, 21917755.
33. Pluskal T, Castillo S, Villar-Briones A, Oresic M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 2010, 11:395. [http://dx.doi.org/10.1186/1471-2105-11-395], 10.1186/1471-2105-11-395, 2918584, 20650010.
34. Ducret A, Van Oostveen I, Eng JK, Yates 3rd J, Aebersold R. High throughput protein characterization by automated reverse-phase chromatography/electrospray tandem mass spectrometry. Protein Sci 1998, 7(3):706-719. [http://dx.doi.org/10.1002/pro.5560070320].
35. Di Silvestre D, Daminelli S, Brunetti P, Mauri PL. Bioinformatics Tools for Mass Spectrometry-Based Proteomics Analysis 2010, Reviews in Pharmaceutical and Biomedical Analysis - BENTHAM SCIENCE PUBLISHERS, 3:30-52. (ISBN 978-1-60805-190-8).
36. Zhang B, VerBerkmoes NC, Langston MA, Uberbacher E, Hettich RL, Samatova NF. Detecting differential and correlated protein expression in label-free shotgun proteomics. J Proteome Res 2006, 5(11):2909-2918. [http://dx.doi.org/10.1021/pr0600273], 10.1021/pr0600273, 17081042.
37. Mitchell T. Machine Learning 1997, New York, NY, USA: McGraw-Hill, Inc.
38. Jackson JE. A Users' Guide to Principal Components 1991, New York: Wiley.
39. Arneberg R, Rajalahti T, Flikka K, Berven FS, Kroksveen AC, Berle M, Myhr KM, Vedeler CA, Ulvik RJ, Kvalheim OM. Pretreatment of mass spectral profiles: application to proteomic data. Anal Chem 2007, 79(18):7014-7026. [http://dx.doi.org/10.1021/ac070946s], 10.1021/ac070946s, 17711295.
40. Zoppis I, Gianazza E, Borsani M, Chinello C, Mainini V, Galbusera C, Ferrarese C, Galimberti G, Sorbi S, Borroni B, Magni F, Antoniotti M, Mauri G. Mutual information optimization for mass spectra data alignment. IEEE/ACM Trans Comput Biol Bioinformatics 2012, 9(3):934-939.
41. Liu H, Sadygov RG, Yates 3rd JR. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004, 76(14):4193-4201. [http://dx.doi.org/10.1021/ac0498563], 10.1021/ac0498563, 15253663.
42. Albrethsen J, Bøgebo R, Møller CH, Olsen JA, Raskov HH, Gammeltoft S. Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer. Proteomics Clin Appl 2012, 6(3-4):182-189. [http://dx.doi.org/10.1002/prca.201100095], 10.1002/prca.201100095, 22532454.
43. Gallien S, Duriez E, Crone C, Kellmann M, Moehring T, Domon B. Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer. Mol Cell Proteomics 2012, 11(12):1709-1723. [http://dx.doi.org/10.1074/mcp.O112.019802], 10.1074/mcp.O112.019802, 22962056.
44. Bern M, Finney G, Hoopmann MR, Merrihew G, Toth MJ, MacCoss MJ. Deconvolution of mixture spectra from ion-trap data-independent-acquisition tandem mass spectrometry. Anal Chem 2010, 82(3):833-841. [http://dx.doi.org/10.1021/ac901801b], 10.1021/ac901801b, 2813958, 20039681.
45. Gillet LC, Navarro P, Tate S, Røst H, Selevsek N, Reiter L, Bonner R, Aebersold R. Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics 2012, 11(6):O111.016717. [http://dx.doi.org/10.1074/mcp.O111.016717], 10.1074/mcp.O111.016717, 22261725.